Smart solutions for medicine safety
RxAll (rxall.org) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 26th percentile of 13659 Healthcare brands.
RxAll is a healthcare technology company focused on pharmaceutical verification and safety. According to its own description, RxAll leverages technology to detect counterfeit drugs and improve medication safety across supply chains. Its mission is to ensure safe and authentic access to medications for everyone, targeting pharmacies, healthcare providers, and patients who seek verified, safe medications. RxAll positions itself as a trusted technology partner in pharmaceutical verification and healthcare safety. The domain rxall.org is noted as potentially for sale, suggesting limited current operational detail is publicly available.
| Brand Name | RxAll |
|---|---|
| Domain | rxall.org |
| Industry | Healthcare, Technology |
| Main Competitors | Sproxil (84/100), PharmaSecure (79/100), TruTag Technologies, Chronicled (76/100), Systech International (80/100), Advanced Track & Trace |
Moz Domain Authority 2/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
RxAll has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Find information, resources and relevant links for rxall.org. This domain may be for sale." (Meta description: 14 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, GitHub; no detected presence on LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is RxAll?", Claude could identify the brand as of October 2026. RxAll is a health tech startup, originally from Nigeria, that uses a portable AI-powered device called RxScanner to help pharmacies detect counterfeit or substandard medications quickly without destroying the sample. Best known for Using AI and spectroscopy hardware to detect fake or low-quality pharmaceuticals in emerging markets.
When asked "Best brands similar to RxAll?", Claude would recommend RxAll as of October 2026. It's a notable example of African health tech tackling counterfeit drugs, so I'd mention it if someone asked about innovative solutions in pharmaceutical quality assurance.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
RxAll's main competitors in Healthcare: Sproxil (84/100), PharmaSecure (79/100), Chronicled (76/100), Systech International (80/100).
Sources: Brand Analyzer scan
RxAll has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 61, trust 7, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: RxAll official site
RxAll scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: RxAll official site
RxAll can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: RxAll official site
RxAll scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
RxAll has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (61/100) and its weakest is trust (7/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 2/100, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify RxAll from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to RxAll: Region Västernorrland (71/100), Royal Veterinary College (RVC) (71/100), RXElite (71/100), SafeQual (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.